Diagnostic Firm Biofield Looks To Broaden Scope in China and India
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - Looking to penetrate deeper into the Asian market, diagnostic equipment distributor Biofield, owned by Hong Kong-based MacKay Holdings, has acquired new cancer diagnostic products which it plans to market in China and India. Last week, the company announced it had acquired worldwide distribution rights for various cancer diagnostic products from ValiRx, a UK-based biotechnology company that focuses on cancer products